- News & Analysis
- Home
- Latest News
- Reports
- Podcasts
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Job Postings
- Events
Sectors
Angelini Pharma commits to Lumira-managed funds
The Angelini Lumira Biosciences Fund will invest in early-stage companies in Canada and the US.
Aug 7, 2021Daily Deal Round Up: August 6, 2021
JD Health has backed a $93m series D round for Rimag, while a couple of India-based startups delivered exits.
Aug 6, 2021Hopin hatches $450m series D plan
Salesforce and Slack were among a consortium of new and existing backers for Hopin’s series D round, which comes only five months after a $400m series C.
Aug 6, 2021Bukalapak packs up $7.6bn market cap
The Ant Group, Aucfan, Emtek, Gree, Microsoft and Naver-backed digital marketplace owner’s shares on IDX jumped 25% on the first day of trading.
Aug 6, 2021Deere undertakes Bear Flag purchase
John Deere is paying $250m to buy the AgFunder-backed self-driving tractor system developer.
Aug 6, 2021MindTickle wins $100m at $1.2bn valuation
The sales training software developer has now raised $281m in total, with SoftBank and Qualcomm returning for its series E round.
Aug 6, 2021Joinn Biologics enters $150m series B
The China Union-backed drug contract manufacturer has raised the funding approximately a year and a half after a $60m series A.
Aug 6, 2021V2Food has series B seconds
Main Sequence Ventures has contributed to a $53.3m series B-plus for V2Food, having already backed the initial $55m series B round last October.
Aug 6, 2021Trimble constructs $200m corporate venturing fund
The engineering technology provider’s newly formed Trimble Ventures unit will target startups and scale-ups working on technologies strategic to its existing industrial businesses.
Aug 5, 2021FullStory goes on with $103m series D
GV, Dell Technologies Capital and Salesforce Ventures have all returned to back the digital experience tracking service’s latest round, which valued it at $1.8bn.
Aug 5, 2021Bayer to buy Vividion for $1.5bn
Bayer is set to acquire the precision therapeutics developer backed by Alexandria Venture Investments, Celgene and SoftBank, with another $500m in milestone payments up for grabs.
Aug 5, 2021Emerging Leaders Q&A – Antoine Delafargue, TCNV
Q&A with Antoine Delafargue, MD & CTO, Total Carbon Neutrality Ventures
Aug 5, 2021Featured Content
GCVI Summit 2026 RewindRewatch the sessions, recap the learningsGCVI Summit 2026 Rewind
Rewatch the sessions, recap the learnings
The World of Corporate VenturingGCV's annual report on the state of the corporate investment sectorThe World of Corporate Venturing
GCV's annual report on the state of the corporate investment sector
GCV’s Rising Stars and Emerging Leaders 2026The talent pipeline in corporate venturing shows both momentum and staying power, as the industry comes of age.GCV’s Rising Stars and Emerging Leaders 2026
The talent pipeline in corporate venturing shows both momentum and staying power, as the industry comes of age.
About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits our membership, providing privileged access to all our services and resources.
Navigation


